3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
558
Leukemia
281
Precursor Cell Lymphoblastic Leukemia-Lymphoma
231
Lymphoma
159
Myelodysplastic Syndromes
110
Burkitt Lymphoma
90
Congenital Abnormalities
85
Lymphoma, Non-Hodgkin
84
Leukemia, Monocytic, Acute
83
Leukemia, Myelomonocytic, Acute
81
Lymphoma, Large B-Cell, Diffuse
79
Leukemia, Erythroblastic, Acute
74
Leukemia, Megakaryoblastic, Acute
71
Recurrence
69
Lymphoma, Mantle-Cell
69
Lymphoma, Follicular
48
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Hodgkin Disease
43
Lymphoma, Large-Cell, Immunoblastic
36
Blast Crisis
36
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
32
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
27
Lymphoma, B-Cell, Marginal Zone
23
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Trastuzumab
597
Paclitaxel
562
Cyclophosphamide
545
Docetaxel
479
Capecitabine
388
Letrozole
350
Fulvestrant
311
Doxorubicin
285
Carboplatin
277
Tamoxifen
257
Anastrozole
219
exemestane
211
Epirubicin
210
Radiotherapy
197
Bevacizumab
189
pertuzumab
177
Gemcitabine
163
Vinorelbine
162
pembrolizumab
161
Lapatinib
161
palbociclib
152
Exercise
132
Fluorouracil
118
Albumin-Bound Paclitaxel
116
eribulin
108
Magnetic Resonance Spectroscopy
108
130-nm albumin-bound paclitaxel
107
Everolimus
103
Taxes
96
Cisplatin
92
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Breast Neoplasms
×
Cytarabine
×
Clear all
NCT01645839
2019-06-12
DEPOSEIN
Centre Oscar Lambret
Phase 3
Completed
74 enrolled